Winton Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,334
Closed -$1.19M 1024
2025
Q1
$1.19M Buy
5,334
+1,772
+50% +$397K 0.07% 274
2024
Q4
$1.17M Buy
3,562
+981
+38% +$321K 0.08% 242
2024
Q3
$775K Buy
2,581
+292
+13% +$87.6K 0.05% 366
2024
Q2
$754K Buy
2,289
+797
+53% +$263K 0.05% 372
2024
Q1
$590K Buy
+1,492
New +$590K 0.04% 448
2023
Q4
Sell
-924
Closed -$347K 867
2023
Q3
$347K Sell
924
-530
-36% -$199K 0.03% 497
2023
Q2
$556K Sell
1,454
-2,385
-62% -$912K 0.05% 279
2023
Q1
$1.33M Buy
3,839
+2,153
+128% +$746K 0.08% 344
2022
Q4
$397K Sell
1,686
-933
-36% -$220K 0.03% 708
2022
Q3
$644K Buy
2,619
+130
+5% +$32K 0.04% 566
2022
Q2
$753K Sell
2,489
-325
-12% -$98.3K 0.04% 578
2022
Q1
$1.16M Sell
2,814
-842
-23% -$346K 0.06% 417
2021
Q4
$1.72M Sell
3,656
-2,043
-36% -$958K 0.1% 274
2021
Q3
$2.42M Sell
5,699
-231
-4% -$98.1K 0.14% 127
2021
Q2
$2.13M Buy
5,930
+2,211
+59% +$794K 0.11% 163
2021
Q1
$1.05M Buy
3,719
+1,054
+40% +$297K 0.06% 431
2020
Q4
$755K Sell
2,665
-14,218
-84% -$4.03M 0.05% 566
2020
Q3
$4.64M Sell
16,883
-28,504
-63% -$7.84M 0.15% 143
2020
Q2
$10.3M Sell
45,387
-86,437
-66% -$19.6M 0.27% 38
2020
Q1
$20.1M Buy
131,824
+53,937
+69% +$8.21M 0.53% 5
2019
Q4
$11.7M Buy
77,887
+15,989
+26% +$2.4M 0.16% 185
2019
Q3
$8.78M Buy
61,898
+59,625
+2,623% +$8.46M 0.1% 237
2019
Q2
$284K Sell
2,273
-2,137
-48% -$267K 0.01% 922
2019
Q1
$486K Sell
4,410
-508
-10% -$56K 0.01% 597
2018
Q4
$482K Sell
4,918
-241
-5% -$23.6K 0.01% 500
2018
Q3
$637K Sell
5,159
-404
-7% -$49.9K 0.01% 536
2018
Q2
$552K Sell
5,563
-10,176
-65% -$1.01M 0.01% 610
2018
Q1
$1.39M Sell
15,739
-41,381
-72% -$3.65M 0.04% 405
2017
Q4
$5.64M Buy
+57,120
New +$5.64M 0.16% 223